Stay updated on Phase 1 Study in Relapsed/Refractory Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Phase 1 Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 1 Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.1 to v3.0.2; removed the 'Back to Top' element.
    Difference
    0.6%
    Check dated 2025-09-14T00:25:44.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.6%
    Check dated 2025-09-06T21:14:38.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location details, while several location-related terms have been removed.
    Difference
    32%
    Check dated 2025-08-30T15:46:07.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T12:25:30.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.3%
    Check dated 2025-08-09T08:01:25.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    4%
    Check dated 2025-08-02T04:13:40.000Z thumbnail image

Stay in the know with updates to Phase 1 Study in Relapsed/Refractory Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 1 Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page.